The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In FLC tumors there is a single, consistent genetic deletion in one copy of chromosome 194,5.”
From Conformational Landscape of the PRKACA-DNAJB1 Chimeric Kinase, the Driver for Fibrolamellar Hepatocellular Carcinoma (2018) · cites this paper as [5]
In the citing paper
“However, this chimera is the only detected structural alteration of the genome5.”
From Conformational Landscape of the PRKACA-DNAJB1 Chimeric Kinase, the Driver for Fibrolamellar Hepatocellular Carcinoma (2018) · cites this paper as [5]
In the citing paper
“There is compelling evidence that the J-PKAcα chimera is the main driver for the development of FLC4–6.”
From Conformational Landscape of the PRKACA-DNAJB1 Chimeric Kinase, the Driver for Fibrolamellar Hepatocellular Carcinoma (2018) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The UCSC Genome Browser database: 2014 update
Karolchik, D., Barber, G. P., Casper, J., Clawson, H., Cline, M. S., Diekhans, M., Dreszer, T. R., Fujita, P. A., Guruvadoo, L., Haeussler, M., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1168 · Cited by 670
Research works printed but not linked: 60
- Omata, 1980, Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features, Cancer, 46, 372, 10.1002/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S · doi:10.1002/1097-0142(19800715)46:2<372::aid-cncr2820460227>3.0.co;2-s
- Meyers, 2007, Tumors of the liver in children, Surg Oncol, 16, 195, 10.1016/j.suronc.2007.07.002 · DOI · Paper page
- Sheahan, 1988, Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature, Hum Pathol, 19, 784, 10.1016/S0046-8177(88)80261-2 · doi:10.1016/s0046-8177(88)80261-2
- Williams, 2025, High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma, Br Med J (Clin Res Ed), 840
- Brock, 2013, Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma - Results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience, Eur J Cancer, 49, 2698, 10.1016/j.ejca.2013.04.012 · DOI
- Pawlik, 2014, Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: a national perspective, Journal of the American College of Surgeons, 218, 196, 10.1016/j.jamcollsurg.2013.10.011 · DOI
- Ditah, 2014, Prognosis of Patients With Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma: A Systematic Review and Meta-analysis, Gastrointest Cancer Res, 7, 49
- Blumgart, 1984, Neurotensin secretion by fibrolamellar carcinoma of the liver, Lancet, 10, 538
- Evers, 1994, Expression of the neurotensin gene in fetal human liver and fibrolamellar carcinoma, Ann Surg, 220
- Rossiter, 1986, Transcobalamin I as a “marker” for fibrolamellar hepatoma, Med Pediatr Oncol, 227
- Orsatti, Greenberg, Rolfes, Ishak, Paronetto. DNA ploidy of fibrolamellar hepatocellular carcinoma by image analysis. Hum Pathol. 1994/09/01; 936–9. · DOI
- Kreipe, 2000, Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization, Am J Clin Pathol [Internet], 114, 867, 10.1309/BMTT-JBPD-D13H-1UVD · doi:10.1309/bmtt-jbpd-d13h-1uvd
- Timmons, 1996, Report of a complex karyotype in recurrent metastatic fibrolamellar hepatocellular carcinoma and a review of hepatocellular carcinoma cytogenetics, Cancer Genet Cytogenet, 170
- Habib, 1993, Infrequent chromosome allele loss in fibrolamellar carcinoma, Br J Cancer [Internet], 67, 244, 10.1038/bjc.1993.47 · doi:10.1038/bjc.1993.47
- Peters, 1986, Mitochondrial abnormalities in hepatocytes adjacent to fibrolamellar hepatocellular carcinoma, J Tongji Med Univ, 6, 26, 10.1007/BF02911614 · doi:10.1007/bf02911614
- Vivekanandan, Daniel, Yeh, Torbenson. Mitochondrial mutations in hepatocellular carcinomas and fibrolamellar carcinomas. Mod Pathol. 2010/03/17; 790–8. · DOI
- Belote, 2014, Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma, Science, 343, 1010, 10.1126/science.1249484 · DOI · Paper page
- Ding, 2012, MuSiC: identifying mutational significance in cancer genomes, Genome Res, 22, 1589, 10.1101/gr.134635.111 · DOI · Paper page
- Tanabe, 2014, Data, information, knowledge and principle: back to metabolism in KEGG, Nucleic Acids Res, 42, D199, 10.1093/nar/gkt1076 · DOI · Paper page
- McKenna, 2013, Mutational heterogeneity in cancer and the search for new cancer-associated genes, Nature. Nature, 499, 214, 10.1038/nature12213 · DOI · Paper page
- Korbel, 2012, DELLY: structural variant discovery by integrated paired-end and split-read analysis, Bioinformatics, 28, i333, 10.1093/bioinformatics/bts378 · DOI · Paper page
- Edmondson, 1956, Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood, AMA J Dis Child, 91, 168
- Bowman, 2003, Fibrolamellar hepatocellular carcinoma in children and adolescents, Cancer, 2006
- Raymond, 2012, Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection, Cancer, 4981
- Hassan, 2013, Prognostic Indicators and Treatment Outcome in 94 Cases of Fibrolamellar Hepatocellular Carcinoma, Oncology, 85, 197, 10.1159/000354698 · doi:10.1159/000354698
- Klimstra, 2010, Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation, Mod Pathol [Internet], 23, 1180, 10.1038/modpathol.2010.105 · doi:10.1038/modpathol.2010.105
- Kiss, 2012, Molecular characteristics of fibrolamellar hepatocellular carcinoma, Pathol Oncol Res [Internet], 19, 63
- Buckley, Burgart, Kakar. Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma. Hum Pathol. 2006/03/28; 410–4. · DOI
- Kinzler, 2013, Cancer genome landscapes, Science (New York, NY), 339, 1546, 10.1126/science.1235122 · DOI · Paper page
- Kufe, 2009, Mucins in cancer: function, prognosis and therapy, Nat Rev Cancer, 9, 874, 10.1038/nrc2761 · DOI · Paper page
- Carothers Carraway, 2009, Muc4/MUC4 functions and regulation in cancer, Future Oncol, 5, 1631, 10.2217/fon.09.125 · DOI
- Carraway, 2011, MUC1 and MUC4: switching the emphasis from large to small, Cancer Biother Radiopharm, 26, 261, 10.1089/cbr.2011.1017 · DOI
- Ranade, 2014, Genome Reference and Sequence Variation in the Large Repetitive Central Exon of Human MUC5AC, Am J Respir Cell Mol Biol, 50, 223, 10.1165/rcmb.2013-0235OC · DOI
- Stratton, 2008, The Catalogue of Somatic Mutations in Cancer (COSMIC), Curr Protoc Hum Genet
- Sunyaev, 2009, Human mutation rate associated with DNA replication timing, Nature Genetics, 41, 393, 10.1038/ng.363 · DOI · Paper page
- Hyrien, 2010, Impact of replication timing on non-CpG and CpG substitution rates in mammalian genomes, Genome Res, 20, 447, 10.1101/gr.098947.109 · DOI · Paper page
- Hashash, Thudi, Malik. An 18-year-old woman with a 15-cm liver mass and an ammonia level of 342. Gastroenterology. 2012/09/25; 1401; 1157–2. · doi:10.1053/j.gastro.2012.07.002
- Tejo, 2012, [Hyperammonemic encephalopathy and fibrolamellar hepatocellular carcinoma], Medicina (B Aires), 72, 425
- Revankar, 2009, Hyperammonemic encephalopathy: a rare presentation of fibrolamellar hepatocellular carcinoma, Am J Med Sci, 338, 522, 10.1097/MAJ.0b013e3181bccfb4 · doi:10.1097/maj.0b013e3181bccfb4
- Liu, 2011, DNA Methylation Suppresses Expression of the Urea Cycle Enzyme Carbamoyl Phosphate Synthetase 1 (CPS1) in Human Hepatocellular Carcinoma, Am J Pathol. Elsevier Inc, 178, 652, 10.1016/j.ajpath.2010.10.023 · DOI
- Fan, 2011, CREST maps somatic structural variation in cancer genomes with base-pair resolution, Nat Methods, 8, 652, 10.1038/nmeth.1628 · DOI · Paper page
- Runz, 2014, Sequencing of a patient with balanced chromosome abnormalities and neurodevelopmental disease identifies disruption of multiple high risk loci by structural variation, PLoS ONE, 9, e90894, 10.1371/journal.pone.0090894 · DOI
- Scherer, 2014, The Database of Genomic Variants: a curated collection of structural variation in the human genome, Nucleic Acids Res, 42, D986, 10.1093/nar/gkt958 · DOI · Paper page
- Waxman, 2011, Fibrolamellar Carcinoma: A Review with Focus on Genetics and Comparison to Other Malignant Primary Liver Tumors, Semin Liver Dis, 061
- Cleary, Jeck, Zhao, Selitsky. Identification of driver genes in hepatocellular carcinoma by exome sequencing - Cleary - Hepatology - Wiley Online Library. 2013. · DOI
- Chevet, 2012, Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma, Nature Genetics, 44, 694, 10.1038/ng.2256 · DOI · Paper page
- Li, 2014, Long noncoding RNAs: Novel insights into hepatocelluar carcinoma, Cancer Lett, 344, 20, 10.1016/j.canlet.2013.10.021 · DOI · Paper page
- Shimotohno, 2006, Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues, Oncogene, 25, 2537, 10.1038/sj.onc.1209283 · DOI · Paper page
- Shibata, 2013, Comprehensive genome sequencing of the liver cancer genome, Cancer Lett, 340, 234, 10.1016/j.canlet.2012.10.035 · DOI
- Davidson, 2001, Genomic homogeneity in fibrolamellar carcinomas, Gut, 49, 82, 10.1136/gut.49.1.82 · doi:10.1136/gut.49.1.82
- Durbin, 2008, Mapping short DNA sequencing reads and calling variants using mapping quality scores, Genome Res, 18, 1851, 10.1101/gr.078212.108 · DOI · Paper page
- DePristo, 2010, The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data, Genome Res, 20, 1297, 10.1101/gr.107524.110 · DOI · Paper page
- Wilson, 2012, VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing, Genome Res, 22, 568, 10.1101/gr.129684.111 · DOI · Paper page
- Hall, 2010, BEDTools: a flexible suite of utilities for comparing genomic features, Bioinformatics, 26, 841, 10.1093/bioinformatics/btq033 · DOI · Paper page
- Ishii, 2011, High aromatase activity and overexpression of epidermal growth factor receptor in fibrolamellar hepatocellular carcinoma in a child, J Pediatr Hematol Oncol. [Internet], e195
- Honda, Sbisa, Tullo, Papeo, Saccone, Poole, Pignatelli, Mitry, Ding, Isla, Davies, Habib. p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation. Br J Cancer. 1998/03/26; 776–82. · DOI
- Schirmacher, 2005, Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade-results of an explorative CGH meta-analysis, Br J Cancer, 92, 935, 10.1038/sj.bjc.6602448 · DOI
- Kakar, Chen, Ho, Burgart, Sahai, Dachrut, Yabes, Jain, Ferrell. Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization. Mod Pathol. Nature Publishing Group. Nov 7. 2008/11/11; 134–41. · doi:10.1038/modpathol.2008.178
- Marchio, Pineau, Meddeb, Terris, Tiollais, Bernheim, Dejean. Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients. Oncogene. 3AD. Jul 30. 2000/08/19; 3733–8. · doi:10.1038/sj.onc.1203713
- Terracciano, Tornillo, Avoledo, Schweinitz Von, Kuhne, Bruder. Fibrolamellar hepatocellular carcinoma occurring 5 years after hepatocellular adenoma in a 14-year-old girl: a case report with comparative genomic hybridization analysis. Arch Pathol Lab Med. 2004/01/23; 222–6. · doi:10.5858/2004-128-222-fhcoya
Cited by
Functional and genetic deconstruction of the cellular origin in liver cancer
Marquardt, J. U., Andersen, J. B., & Thorgeirsson, S. S. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4017 · Cited by 306
Rajendran, B. K., & Deng, C.-X. (2017) · Oncotarget · doi:10.18632/oncotarget.17225 · Cited by 73
Tomasini, M. D., Wang, Y., Karamafrooz, A., Li, G., Beuming, T., Gao, J., Taylor, S. S., Veglia, G., & Simon, S. M. (2018) · Scientific Reports · doi:10.1038/s41598-017-18956-w · Cited by 30
Self-citation
Metadata
- Authors
- Darcy, D. G., Chiaroni-Clarke, R., Murphy, J. M., Honeyman, J. N., Bhanot, U., LaQuaglia, M. P., & Simon, S. M.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-01-02
- Volume
- 6
- Issue
- 2
- Pages
- 755-770
- ISSN
- 1949-2553
- Cited by
- 64
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.